nach oben

Erschienen in:

09.01.2019 | Original Article

Calcium and vitamin D supplement intake may increase arterial stiffness in systemic lupus erythematosus patients

verfasst von: Susana Mellor-Pita, Pablo Tutor-Ureta, Silvia Rosado, Khusama Alkadi, Fernando Granado, Carlos Jimenez-Ortiz, Raquel Castejon

Erschienen in: Clinical Rheumatology | Ausgabe 4/2019

Einloggen, um Zugang zu erhalten

Abstract

Objectives

Low serum levels of 25-hydroxyvitamin D (25(OH)D) have been associated with a higher frequency of risk factors and cardiovascular disease. The aim of this study is to evaluate the association of 25(OH)D, cardiovascular risk factors, and subclinical atherosclerosis in systemic lupus erythematosus (SLE) patients.

Method

Forty-seven female SLE patients were studied. Data collected included demographics, SLE activity, disease damage, cardiovascular risk factors, and markers of subclinical atherosclerosis. Patient treatments and vitamin D and calcium supplementation (VitD-Ca) were recorded. Vitamin D deficiency was defined as serum 25(OH)D < 50 nmol/l measured by ultra-high-performance liquid chromatography. Atherosclerosis was assessed by measuring the carotid-femoral pulse wave velocity (PWV) by Doppler velocimetry and intima-media thickness (IMT) by B-mode ultrasound scanning.

Results

61.7% of patients were vitamin D deficient with a mean level of 31.91 ± 10.21 nmol/l. Serum vitamin D concentration was significantly higher in the 23 patients taking VitD-Ca supplements than that in patients not supplemented (p = 0.004). No significant association was found between 25(OH)D serum levels and cardiovascular risk factors, disease activity, or different treatments for SLE. A significant positive correlation was found between 25(OH)D levels, PWV (p = 0.02), and IMT (p = 0.01); moreover, patients taking VitD-Ca supplements presented an increased arterial stiffness.

Conclusion

Patients with arterial stiffness showed higher levels of serum vitamin D and most of them were on VitD-Ca supplements. Although prospective studies with a larger number of patients and follow-up are needed, our findings suggest that VitD-Ca supplementation may have effects on SLE patients’ arterial stiffness.

Urowitz MB, Bookman AAM, Koehler BE, Gordon DA, Smythe HA, Ogryzlo MA (1976) The bimodal mortality pattern of systemic lupus erythematosus. Am J Med 60:221–225CrossRefPubMed

Manzi S, Meilahn EN, Rairie JE, Conte CG, Medsger TA Jr, Jansen-McWilliams L, D’Agostino RB, Kuller LH (1997) Age-specific rates of myocardial infarction and angina in women with systemic lupus erythematosus: comparison with the Framingham study. Am J Epidemiol 145:408–415CrossRefPubMed

Petri M, Perez-Gutthann S, Spence D, Hochberg M (1992) Risk factors for coronary artery disease in patients with systemic lupus erythematosus. Am J Med 93:513–519CrossRefPubMed

Bruce IN, Urowitz M, Gladman D, Ibañez D, Steiner G (2003) Risk factors for coronary heart disease in women with systemic lupus erythematosus. Arthritis Rheum 48:3159–3167CrossRefPubMed

Esdaile JM, Abrahamowicz M, Grodzicky T, Li Y, Panaritis C, du Berger R, Côte R, Grover SA, Fortin PR, Clarke AE, Senécal JL (2001) Traditional Framingham risk factors fail to fully account for accelerated atherosclerosis in systemic lupus erythematosus. Arthritis Rheum 44:2331–2337CrossRefPubMed

Holick MF (2007) Vitamin D deficiency. N Engl J Med 357:266–281CrossRefPubMed

Hewison M (2010) Vitamin D and the immune system: new perspectives on and old theme. Endocrinol Metab Clin N Am 39:365–379CrossRef

Martins D, Wolf M, Pan D, Zadshir A, Tareen N, Thadhani R, Felsenfeld A, Levine B, Mehrotra R, Norris K (2007) Prevalence of cardiovascular risk factors and the serum levels of 25-hydroxyvitamina D in the United States: data from the Third National Health and Nutrition Examination Survey. Arch Intern Med 167:1159–1165CrossRefPubMed

Kunutsor SK, Apekey TA, Steur M (2013) Vitamin D and risk of future hypertension: meta-analysis of 283-537 participants. Eur J Epidemiol 28:205–211CrossRefPubMed

10.

Song Y, Wang L, Pittas AG, Del Gobbo LC, Zhang C, Manson JE, Hu FB (2013) Blood 25-hydroxyvitamin D levels and incident type 2 diabetes: a meta-analysis of prospective studies. Diabetes Care 36:1422–1428CrossRefPubMedPubMedCentral

11.

Skaaby T, Husemoen LL, Pisinger C, Jørgensen T, Thuesen BH, Rasmussen K, Fenger M, Rossing P, Linneberg A (2013) Vitamin D status and 5-year changes in urine albumin creatinine ratio and parathyroid hormone in a general population. Endocrine 44:473–480CrossRefPubMed

12.

Watson KE, Abrolat ML, Malone LL, Hoeg JM, Doherty T, Detrano R, Demer LL (1997) Active serum vitamin D levels are inversely correlated with coronary calcification. Circulation 96:1755–1760CrossRefPubMed

13.

Jablonski KL, Chonchol M, Pierce GL, Walker AE, Seals DR (2011) 25-hydroxyvitamin D deficiency is associated with inflammation-linked vascular endothelial in middle-aged and older adults. Hypertension 57:63–69CrossRefPubMed

14.

Giovannucci E, Liu Y, Hollis BW, Rimm EB (2008) 25-Hydroxyvitamin D and risk of myocardial infarction in men: a prospective study. Arch Intern Med 168:1174–1180CrossRefPubMedPubMedCentral

15.

Kendrick J, Targher G, Smits G, Chonchol M (2009) 25-Hydroxyvitamin D deficiency is independently associated with cardiovascular disease in the Third National Health and Nutrition Examination Survey. Atherosclerosis 205:255–260CrossRefPubMed

16.

Nsengiyumva V, Fernando ME, Moxon JV, Krishna SM, Pinchbeck J, Omer SM, Morris DR, Jones RE, Moran CS, Seto SW, Golledge J (2015) The association of circulating 25-hydroxyvitamin D concentration with peripheral arterial disease: a meta-analysis of observational studies. Atherosclerosis 243:645–651CrossRefPubMed

17.

Sun Q, Pan A, Hu FB, Manson JE, Rexrode KM (2012) 25-hydroxyvitamin D levels and the risk of stroke: a prospective study and meta-analysis. Stroke 43:1470–1477CrossRefPubMedPubMedCentral

18.

Kamen DL, Cooper GS, Bouali H, Shaftman SR, Hollis BW, Gilkeson GS (2006) Vitamin D deficiency in systemic lupus erythematosus. Autoimmun Rev 5:114–117CrossRefPubMed

19.

Borba V, Vieira JG, Kasamatsu T, Radominski SC, Sato E, Lazaretti-Castro M (2009) Vitamin D deficiency in patients with active systemic lupus erythematosus. Osteoporosis Int 20:427–433CrossRef

20.

Amital H, Szekanecz Z, Szücs G, Dankó K, Nagy E, Csépány T, Kiss E, Rovensky J, Tuchynova A, Kozakova D, Doria A, Corocher N, Agmon-Levin N, Barak V, Orbach H, Zandman-Goddard G, Shoenfeld Y (2010) Serum concentrations of 25-OH vitamin D in patients with systemic lupus erythematosus (SLE) are inversely related to disease activity: is it time to routinely supplement patients with SLE with vitamin D? Ann Rheum Dis 69:1155–1157CrossRefPubMed

21.

Wu PW, Rhew EY, Dyer AR, Dunlop DD, Langman CB, Price H, Sutton-Tyrrell K, McPherson DD, Edmundowicz D, Kondos GT, Ramsey-Goldman R (2009) 25-Hydroxyvitamin D and cardiovascular risk factors in women with systemic lupus eryhematosus. Arthritis Rheum 61:1387–1395CrossRefPubMedPubMedCentral

22.

Cusack C, Danby C, Fallon JC, Ho WL, Murray B, Brady J, O’Kelly P, Ambrose N, Kearns G, Murphy GM (2008) Photoprotective behaviour and sunscreen use: impact on vitamin D levels in cutaneous lupus erythematosus. Photodermatol Photoimmunol Photomed 24:260–267CrossRefPubMed

23.

Reference Values for Arterial Stiffness’ Collaboration (2010) Determinants of pulse wave velocity in healthy people and in the presence of cardiovascular risk factors: ‘establishing normal and reference values’. Eur Heart J 31:2338–2350CrossRef

24.

Ruiz-Irastorza G, Egurbide V, Olivares N, Martínez-Berriotxoa A, Aguirre C (2008) Vitamin D deficiency in systemic lupus erythematosus: prevalence, predictors and clinical consequences. Rheumatology 47:920–923CrossRefPubMed

25.

Lopez-Robles C, Rios-Fernandez R, Callejas-Rubio JL, Ortego-Centeno N (2011) Vitamin D deficiency in a cohort of patients with systemic lupus erythematosus from the South of Spain. Lupus 20:330–331CrossRefPubMed

26.

Reynolds JA, Haque S, Berry JL, Pemberton P, Teh LS, Ho P, Gorodkin R, Bruce IN (2012) 25-Hydroxivitamin D deficiency is associated with increased aortic stiffness in patients with systemic lupus erythematosus. Rheumatology 51:544–551CrossRefPubMed

27.

Lertratanakul A, Wu P, Dyer A, Urowitz M, Gladman D, Fortin P, Bae SC, Gordon C, Clarke A, Bernatsky S, Hanly JG, Isenberg D, Rahman A, Merrill J, Wallace DJ, Ginzler E, Khamashta M, Bruce I, Nived O, Sturfelt G, Steinsson K, Manzi S, Dooley MA, Kalunian K, Petri M, Aranow C, Font J, van Vollenhoven R, Stoll T, Ramsey-Goldman R (2014) 25-hydroxyvitamin D and cardiovascular disease in patients with systemic lupus erythematosus: data from a large international inception cohort. Arthritis Care Res (Hoboken) 66:1167–1176CrossRef

28.

Mok CC, Birmingham DJ, Leung HW, Hebert LA, Song H, Rovin BH (2012) Vitamin D levels in Chinese patients with systemic lupus erythematosus: relationship with disease activity, vascular risk factors and atherosclerosis. Rheumatology (Oxford) 51:644–652CrossRef

29.

Karimzadeh H, Shirzadi M, Karimifar M (2017) The effect of vitamin D supplementation in disease activity of systemic lupus erythematosus patients with vitamin D deficiency: a randomized clinical trial. J Res Med Sci 22:4CrossRefPubMedPubMedCentral

30.

Sabio JM, Vargas-Hitos JA, Martinez Bordonado J, Mediavilla-Garcia JD (2018) Association between non-dipper hypertension and vitamin D deficiency in women with systemic lupus erythematosus. Clin Exp Rheumatol Aug 29

31.

García-Carrasco M, Mendoza-Pinto C, Ayón-Aguilar J, Soto-Santillán P, Rodríguez-Gallegos A, Escamilla-Márquez MA, Méndez-Martínez S (2016) Serum levels of vitamin D in systemic lupus erythematosus patients (SLE) and their relationship with disease activity: longitudinal study. Gac Med Mex 152(Suppl 2):32–37PubMed

32.

Reis JP, von Mühlen D, Michos ED, Miller ER 3rd, Appel LJ, Araneta MR, Barrett-Connor E (2009) Serum vitamin D, parathyroid hormone levels and carotid atherosclerosis. Atherosclerosis 207:585–590CrossRefPubMedPubMedCentral

33.

De Boer IH, Kestenbaum B, Shoben AB, Michos ES, Sarnak MJ, Siscovick DS (2009) 25-Hydroxyvitamin D levels inversely associate with risk for developing coronary artery calcification. J Am Soc Nephrol 20:1805–1812CrossRefPubMedPubMedCentral

34.

Brandenburg VM, Vervloet MG, Marx N (2012) The role of vitamin D in cardiovascular disease: from present evidence to future perspectives. Atherosclerosis 225:253–263CrossRefPubMed

35.

Zittermann A, Kuhn J, Dreier J, Knabbe C, Gummert JF, Börgermann J (2013) Vitamin D status and the risk of major adverse cardiac and cerebrovascular events in cardiac surgery. Eur Heart J 34:1358–1364CrossRefPubMed

36.

Durup D, Jørgensen HL, Christensen J, Tjønneland A, Olsen A, Halkjær J, Lind B, Heegaard AM, Schwarz P (2015) A reverse J-shaped association between serum 25-hydroxyvitamin D and cardiovascular disease mortality: the CopD Study. J Clin Endocrinol Metab 100:2339–2346CrossRefPubMed

37.

Ravenell RL, Kamen DL, Spence JD, Hollis BW, Fleury TJ, Janech MG, Almeida JS, Shaftman SR, Oates JC (2012) Premature atherosclerosis is associated with hypovitaminosis D and angiotensin-converting enzyme inhibitor non-use in lupus patients. Am J Med Sci 344:268–273CrossRefPubMedPubMedCentral

38.

Sabio JM, Vargas-Hitos JA, Martinez-Bordonado J, Navarrete-Navarrete N, Díaz-Chamorro A, Olvera-Porcel C, Zamora M, Jiménez-Alonso J (2015) Association between low 25-hydroxyvitamin D, insulin resistance and arterial stiffness in nondiabetic women with systemic lupus erythematosus. Lupus 24:155–163CrossRefPubMed

39.

Bolland MJ, Avenell A, Baron JA, Grey A, MacLennan GS, Gamble GD, Reid IR (2010) Effect of calcium supplements on risk of myocardial infarction and cardiovascular events: meta-analysis. BMJ 341:c3691CrossRefPubMedPubMedCentral

40.

Reid IR, Bristow SM, Bolland MJ (2015) Calcium supplements: benefits and risks. J Intern Med 278:354–368CrossRefPubMed

41.

Reid IR, Gamble GD, Bolland MJ (2016) Circulating calcium concentrations, vascular disease and mortality: a systematic review. J Intern Med 279:524–540CrossRefPubMed

42.

Norman PE, Powell JT (2014) Vitamin D and cardiovascular disease. Circ Res 114:379–393CrossRefPubMed

43.

Hsia J, Heiss G, Ren H, Allison M, Dolan NC, Greenland P, Heckbert SR, Johnson KC, Manson JE, Sidney S, Trevisan M, Women’s Health Initiative Investigators (2007) Calcium/vitamin D supplementation and cardiovascular events. Circulation 115:846–1854CrossRefPubMed

44.

Manson JE, Allison MA, Carr JJ, Langer RD, Cochrane BB, Hendrix SL, Hsia J, Hunt JR, Lewis CE, Margolis KL, Robinson JG, Rodabough RJ, Thomas AM, Women’s Health Initiative and Women’s Health Initiative-Coronary Artery Calcium Study Investigators (2010) Calcium/vitamin D supplementation and coronary artery calcification in the women’s health initiative. Menopause 17:683–691PubMedPubMedCentral

45.

Bolland MJ, Grey A, Avenell A, Gamble GD, Reid IR (2011) Calcium supplements with or without vitamin D and risk of cardiovascular even: reanalysis of the women’s health initiative limited access dataset and meta-analysis. BMJ 342:d2040CrossRefPubMedPubMedCentral

Titel: Calcium and vitamin D supplement intake may increase arterial stiffness in systemic lupus erythematosus patients
verfasst von: Susana Mellor-Pita
Pablo Tutor-Ureta
Silvia Rosado
Khusama Alkadi
Fernando Granado
Carlos Jimenez-Ortiz
Raquel Castejon
Publikationsdatum: 09.01.2019
Verlag: Springer London
Erschienen in: Clinical Rheumatology / Ausgabe 4/2019
Print ISSN: 0770-3198
Elektronische ISSN: 1434-9949
DOI: https://doi.org/10.1007/s10067-018-04416-x

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

^{Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag}

Kostenlos registrieren

Neu im Fachgebiet Innere Medizin

25.04.2024 | Hypotonie | Nachrichten

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen

Springer Medizin

Calcium and vitamin D supplement intake may increase arterial stiffness in systemic lupus erythematosus patients

Abstract

Objectives

Method

Results

Conclusion

Leitlinien kompakt für die Innere Medizin

Neu im Fachgebiet Innere Medizin

Niedriger diastolischer Blutdruck erhöht Risiko für schwere kardiovaskuläre Komplikationen

Therapiestart mit Blutdrucksenkern erhöht Frakturrisiko

Adjuvante Immuntherapie verlängert Leben bei RCC

Alectinib verbessert krankheitsfreies Überleben bei ALK-positivem NSCLC

Update Innere Medizin

Springer Medizin

Abstract

Objectives

Method

Results

Conclusion

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 4/2019

Utility of neutrophil CD64 and serum TREM-1 in distinguishing bacterial infection from disease flare in SLE and ANCA-associated vasculitis

Optimal care for systemic sclerosis patients: recommendations from a patient-centered and multidisciplinary mixed-method study and working conference

The potential role of Ets-1 and miR-326 in CD19+B cells in the pathogenesis of patients with systemic lupus erythematosus

Frequency and spectrum of outpatient musculoskeletal diagnoses at a pediatric hospital in Kenya

Interobserver agreement using Schlapbach graded scale for diffuse idiopathic skeletal hyperostosis (DISH): can we reduce the cut-off point of vertebral affection?

Correction to: Proposal for a simple algorithm to differentiate adult-onset Still’s disease with other fever of unknown origin causes: a longitudinal prospective study

Leitlinien kompakt für die Innere Medizin

Neu im Fachgebiet Innere Medizin

Niedriger diastolischer Blutdruck erhöht Risiko für schwere kardiovaskuläre Komplikationen

Therapiestart mit Blutdrucksenkern erhöht Frakturrisiko

Adjuvante Immuntherapie verlängert Leben bei RCC

Alectinib verbessert krankheitsfreies Überleben bei ALK-positivem NSCLC

Update Innere Medizin